H.-U. Meier-Kriesche

3.2k total citations · 2 hit papers
43 papers, 2.3k citations indexed

About

H.-U. Meier-Kriesche is a scholar working on Transplantation, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, H.-U. Meier-Kriesche has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Transplantation, 16 papers in Public Health, Environmental and Occupational Health and 15 papers in Surgery. Recurrent topics in H.-U. Meier-Kriesche's work include Renal Transplantation Outcomes and Treatments (33 papers), Organ Transplantation Techniques and Outcomes (15 papers) and Organ Donation and Transplantation (11 papers). H.-U. Meier-Kriesche is often cited by papers focused on Renal Transplantation Outcomes and Treatments (33 papers), Organ Transplantation Techniques and Outcomes (15 papers) and Organ Donation and Transplantation (11 papers). H.-U. Meier-Kriesche collaborates with scholars based in United States, Germany and Austria. H.-U. Meier-Kriesche's co-authors include Kenneth Lamb, Sundus A. Lodhi, Alan B. Leichtman, Rami Bustami, Rainer W.G. Gruessner, John J. Fung, Mark L. Barr, Jesse D. Schold, Bruce Kaplan and Titte R. Srinivas and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Transplantation.

In The Last Decade

H.-U. Meier-Kriesche

43 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

2010 698 citations H.-U. Meier-Kriesche et al. American Journal of Transplantation profile →
Immunosuppression: Evolution in Practice and Trends, 1994–2004

2006 434 citations H.-U. Meier-Kriesche, Rainer W.G. Gruessner et al. American Journal of Transplantation profile →

Peers

Countries citing papers authored by H.-U. Meier-Kriesche

Since Specialization

Citations

This map shows the geographic impact of H.-U. Meier-Kriesche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.-U. Meier-Kriesche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.-U. Meier-Kriesche more than expected).

Fields of papers citing papers by H.-U. Meier-Kriesche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.-U. Meier-Kriesche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.-U. Meier-Kriesche. The network helps show where H.-U. Meier-Kriesche may publish in the future.

Co-authorship network of co-authors of H.-U. Meier-Kriesche

This figure shows the co-authorship network connecting the top 25 collaborators of H.-U. Meier-Kriesche. A scholar is included among the top collaborators of H.-U. Meier-Kriesche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.-U. Meier-Kriesche. H.-U. Meier-Kriesche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies 2018 ·American Journal of Transplantation ·Robert A. Bray, Howard M. Gebel, Robert Townsend, Mustimbo Roberts, Martin S. Polinsky, Lingfeng Yang, H.-U. Meier-Kriesche, Christian P. Larsen	98
2	Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant 2016 ·American Journal of Transplantation ·Sander Florman, Tim Becker, Barbara A. Bresnahan, (unknown), (unknown), (unknown), Ferdinand Muehlbacher, Philip J. O’Connell, H.-U. Meier-Kriesche, Christian P. Larsen	22
3	The Success of Continued Steroid Avoidance After Kidney Transplantation in the US 2009 ·American Journal of Transplantation ·Jesse D. Schold, (unknown), Shehzad Rehman, Joseph F. Magliocca, H.-U. Meier-Kriesche	26
4	The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease 2008 ·Haematologica ·Erin Dunbar, (unknown), (unknown), Jesse D. Schold, H.-U. Meier-Kriesche, Vijay Reddy	44
5	Early immunosuppression exposure and incidence of acute rejection and renal function progression: Evidence from the symphony study 2007 ·American Journal of Transplantation ·H.-U. Meier-Kriesche, Philip F. Halloran, Yves Vanrenterghem, Jesse D. Schold, Henrik Ekberg	2
6	Levels and progression of parameters associated with metabolic syndrome by immunosuppressive regimen: Evidence from the symphony study 2007 ·American Journal of Transplantation ·Yves Vanrenterghem, H.-U. Meier-Kriesche, Jesse D. Schold, (unknown), Henrik Ekberg	3
7	Blood pressure in the first year following renal transplantation is associated with immuno-suppressive regimens: Evidence from the symphony study 2007 ·American Journal of Transplantation ·(unknown), H.-U. Meier-Kriesche, Jesse D. Schold, Yves Vanrenterghem, Henrik Ekberg	4
8	Factors associated with BMI increases early after renal transplantation: Evidence from the symphony study 2007 ·American Journal of Transplantation ·H.-U. Meier-Kriesche, Jesse D. Schold, Yves Vanrenterghem, Philip F. Halloran, Henrik Ekberg	1
9	Value of Posttransplant Antibody Tests in the Evaluation of Patients with Renal Graft Dysfunction 2007 ·American Journal of Transplantation ·Juan C. Scornik, Giselle Guerra, Jesse D. Schold, Titte R. Srinivas, Duska Dragun, H.-U. Meier-Kriesche	60
10	The Expanded Criteria Donor Policy: An Evaluation of Program Objectives and Indirect Ramifications 2006 ·American Journal of Transplantation ·Jesse D. Schold, Richard J. Howard, Michael J. Scicchitano, H.-U. Meier-Kriesche	23
11	Immunosuppression: Evolution in Practice and Trends, 1994–2004 breakdown → 2006 ·American Journal of Transplantation ·H.-U. Meier-Kriesche, (unknown), Rainer W.G. Gruessner, John J. Fung, Rami Bustami, Mark L. Barr, Alan B. Leichtman	434
12	The effects of renal transplantation on circulating precursor dendritic cells 2005 ·Transplantation Proceedings ·Karl L. Womer, Ruihua Peng, Pamela R. Patton, (unknown), Michael N. Bucci, Matthew R. Murawski, Jesse D. Schold, (unknown), Alan W. Hemming, Titte R. Srinivas, H.-U. Meier-Kriesche, Bruce Kaplan, Michael Clare‐Salzler	4
13	Death after graft loss: a novel endpoint for renal tranplantation 2001 ·Transplantation Proceedings ·H.-U. Meier-Kriesche, B. Kaplan	40
14	Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared to sandimmune 2001 ·Transplantation Proceedings ·H.-U. Meier-Kriesche, Bruce Kaplan	2
15	Interaction between acute rejection and recipient age on long-term renal allograft survival 2001 ·Transplantation Proceedings ·H.-U. Meier-Kriesche, Titte R. Srinivas, Bruce Kaplan	39
16	Need for individualized immunosuppression in elderly renal transplant recipients 2001 ·Transplantation Proceedings ·H.-U. Meier-Kriesche, Akinlolu Ojo, Julie Arndorfer, Alan B. Leichtman, Kathleen D. Lake, Diane M. Cibrik, Jeffrey D. Punch, (unknown), Bruce Kaplan	13
17	Long-term benefit of kidney-pancreas transplants in type 1 diabetics 2001 ·Transplantation Proceedings ·Akinlolu Ojo, H.-U. Meier-Kriesche, Julie Arndorfer, Alan B. Leichtman, John C. Magee, Diane M. Cibrik, Robert A. Wolfe, Friedrich K. Port, Lawrence Y. Agodoa, Dixon B. Kaufman, Bruce Kaplan	15
18	Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation 2000 ·Pediatric Nephrology ·Ronald J. Portman, H.-U. Meier-Kriesche, Rita D. Swinford, (unknown), B D Kahan	18
19	ALLOGRAFT LOSS IN RENAL TRANSPLANT RECIPIENTS WITH FABRY???S DISEASE AND ACTIVATED PROTEIN C RESISTANCE 2000 ·Transplantation ·Gary S. Friedman, (unknown), (unknown), (unknown), H.-U. Meier-Kriesche, Bruce Kaplan, Luigi Bonomini, (unknown), Neil Lyman, Shamkant Mulgaonkar, Martin Jacobs	21
20	Correlation Between Pretransplantation Test Dose Cyclosporine Pharmacokinetic Profiles and Posttransplantation Sirolimus Blood Levels in Renal Transplant Recipients 1999 ·Therapeutic Drug Monitoring ·Bruce Kaplan, H.-U. Meier-Kriesche, Kimberly L. Napoli, B D Kahan	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact